Apr 24, 2019 / 12:30PM GMT
Operator
Good day, and welcome to the bioMérieux First Quarter 2019 Business Review Conference Call. Today's conference is being recorded.
At this time, I would like to turn the conference over to Mr. Sylvain Morgeau. Please go ahead, sir.
Sylvain Morgeau - bioMérieux S.A.-IR
Thank you, John. Good day, everyone, and thank you for joining us to review bioMérieux's performance for the first quarter of 2019. As usual, I'm online with Mr. Alexandre Mérieux, CEO; and Mr. Guillaume Bouhours, CFO. Alexandre will start this call with a short introduction to give you his main messages about the quarter, and then most of the call will be dedicated to the Q&A session.
Before I hand the call over to management, please note that this conference call will include forward-looking statements, and I would like to remind you of the usual disclaimers saying that forward-looking statements are based entirely or partially on assessments or judgments that may change or be modified due to uncertainties and risks related to the
Q1 2019 Biomerieux SA Corporate Sales Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot